Literature DB >> 28737937

Asymmetric Hydrogen Bonding Catalysis for the Synthesis of Dihydroquinazoline-Containing Antiviral, Letermovir.

Cheol K Chung1, Zhijian Liu1, Katrina W Lexa1, Teresa Andreani1, Yingju Xu1, Yining Ji1, Daniel A DiRocco1, Guy R Humphrey1, Rebecca T Ruck1.   

Abstract

A weak Brønsted acid-catalyzed asymmetric guanidine aza-conjugate addition reaction has been developed. C2-symmetric, dual hydrogen-bond donating bistriflamides are shown to be highly effective in activating α,β-unsaturated esters toward the intramolecular addition of a pendant guanidinyl nucleophile. Preliminary mechanistic investigation, including density functional theory calculations and kinetics studies, support a conjugate addition pathway as more favorable energetically than an alternative electrocyclization pathway. This methodology has been successfully applied to the synthesis of the 3,4-dihydroquinazoline-containing antiviral, Letermovir, and a series of analogues.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28737937     DOI: 10.1021/jacs.7b05806

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  4 in total

1.  Combining traditional 2D and modern physical organic-derived descriptors to predict enhanced enantioselectivity for the key aza-Michael conjugate addition in the synthesis of Prevymis™ (letermovir).

Authors:  Toni T Metsänen; Katrina W Lexa; Celine B Santiago; Cheol K Chung; Yingju Xu; Zhijian Liu; Guy R Humphrey; Rebecca T Ruck; Edward C Sherer; Matthew S Sigman
Journal:  Chem Sci       Date:  2018-07-18       Impact factor: 9.825

2.  A bifunctional iminophosphorane squaramide catalyzed enantioselective synthesis of hydroquinazolines via intramolecular aza-Michael reaction to α,β-unsaturated esters.

Authors:  Guanglong Su; Connor J Thomson; Ken Yamazaki; Daniel Rozsar; Kirsten E Christensen; Trevor A Hamlin; Darren J Dixon
Journal:  Chem Sci       Date:  2021-03-18       Impact factor: 9.825

3.  Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives.

Authors:  Katharigatta N Venugopala; Nizar A Al-Shar'i; Lina A Dahabiyeh; Wafa Hourani; Pran Kishore Deb; Melendhran Pillay; Bashaer Abu-Irmaileh; Yasser Bustanji; Sandeep Chandrashekharappa; Christophe Tratrat; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Pottathil Shinu; Michelyne Haroun; Mahmoud Kandeel; Abdulmalek Ahmed Balgoname; Rashmi Venugopala; Mohamed A Morsy
Journal:  Antibiotics (Basel)       Date:  2022-06-21

4.  Larvicidal Activities of 2-Aryl-2,3-Dihydroquinazolin -4-ones against Malaria Vector Anopheles arabiensis, In Silico ADMET Prediction and Molecular Target Investigation.

Authors:  Katharigatta N Venugopala; Pushpalatha Ramachandra; Christophe Tratrat; Raquel M Gleiser; Subhrajyoti Bhandary; Deepak Chopra; Mohamed A Morsy; Bandar E Aldhubiab; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Rashmi Venugopala; Pran Kishore Deb; Sandeep Chandrashekharappa; Hany Ezzat Khalil; Osama I Alwassil; Sara Nidal Abed; Yazan A Bataineh; Ramachandra Palenge; Michelyne Haroun; Shinu Pottathil; Meravanige B Girish; Sabah H Akrawi; Viresh Mohanlall
Journal:  Molecules       Date:  2020-03-13       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.